Healthcare-Associated Infections (HAIs) are the most common type of complication for patients who are hospitalized. According to the Center for Disease Control and Prevention, in 2011 there were an estimated 721,800 HAIs in U.S. acute care hospitals that led to about 75,000 deaths and more than $20 billion in healthcare costs. It is well documented that hand hygiene is one of the most effective measures to reduce the transmission of healthcare-associated pathogens and the incidence of healthcare associated infections.
Our sensor-based platform, Sanibit, helps improve hand hygiene compliance, create a safer environment and reduce infection risks.
Every year more than $250 billion was spent on cancer in the United States. In general, more than 90% of cancer-related deaths are related to metastasis. Metastatic precursors in the bloodstream can potentially be pivotal in early cancer detection, personalized medicine and minimal residual disease monitoring. Compared to fresh tissue biopsy, “liquid biopsy” of bio-markers in blood samples is much more accessible and affordable, and is much less invasive.
MagiCyte, our highly sensitive biosensor platform, helps expedite the cutting-edge research in precision medicine.